First Patient Enrolled in DR Congo Ebola Treatment Trial for Bundibugyo Strain
The World Health Organization (WHO) has announced the enrollment of the first patient in a clinical trial for experimental treatments targeting the Bundibugyo Ebola outbreak in the Democratic Republic of Congo. This strain currently lacks approved vaccines or treatments. The outbreak has led to over 1,400 cases and 438 deaths, with response efforts complicated by mistrust and violence.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.